Gene · 6046
Papers3,414
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,414
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex. | Cancer Res | 2023 | 37352376 | PubTator, text mining | PubMed |
| Paralog-based synthetic lethality: rationales and applications. | Front Oncol | 2023 | 37350942 | PubTator, text mining | PubMed |
| The role of loop dynamics in the prediction of ligand-protein binding enthalpy. | Chem Sci | 2023 | 37350814 | PubTator, text mining | PubMed |
| Improvement in persistent idiopathic facial pain with comorbid ADHD using the combination of a dopamine system stabilizer and psychostimulant: A case report. | Clin Case Rep | 2023 | 37346882 | PubTator, text mining | PubMed |
| Novel genes associated with a placental phenotype in knockout mice also respond to cellular stressors in primary human trophoblasts. | Placenta | 2023 | 37331027 | PubTator, text mining | PubMed |
| Structural insight into the human SID1 transmembrane family member 2 reveals its lipid hydrolytic activity. | Nat Commun | 2023 | 37322007 | PubTator, text mining | PubMed |
| In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape. | Sci Adv | 2023 | 37315149 | PubTator, text mining | PubMed |
| Targeting BET Proteins Decreases Hyaluronidase-1 in Pancreatic Cancer. | Cells | 2023 | 37296612 | PubTator, text mining | PubMed |
| Bromo- and Extra-Terminal Domain Inhibitors Induce Mitochondrial Stress in Pancreatic Ductal Adenocarcinoma. | Mol Cancer Ther | 2023 | 37294884 | PubTator, text mining | PubMed |
| Essential role of bromodomain proteins in renal cell carcinoma (Review). | Mol Med Rep | 2023 | 37293842 | PubTator, text mining | PubMed |
| Age-related modifications in CYP-dependent drug metabolism: role of stress. | Front Endocrinol (Lausanne) | 2023 | 37293497 | PubTator, text mining | PubMed |
| Integrated high-throughput analysis identifies super enhancers in metastatic castration-resistant prostate cancer. | Front Pharmacol | 2023 | 37292153 | PubTator, text mining | PubMed |
| Precise Conformational Control Yielding Highly Potent and Exceptionally Selective BRD4 Degraders with Strong Antitumor Activity. | J Med Chem | 2023 | 37289649 | PubTator, text mining | PubMed |
| Structural insights of novel mutational frames in Bromodomain Containing-2 gene (BRD2) in juvenile myoclonic epilepsy: bed, bench, and laptop profiles. | Epilepsy Behav | 2023 | 37276801 | PubTator, text mining | PubMed |
| Metabolomics of infectious diseases in the era of personalized medicine. | Front Mol Biosci | 2023 | 37275959 | PubTator, text mining | PubMed |
| Epigenetic targets in B- and T-cell lymphomas: latest developments. | Ther Adv Hematol | 2023 | 37273421 | PubTator, text mining | PubMed |
| Selective BD2 Inhibitor Exerts Anti-Fibrotic Effects via BRD4/FoxM1/Plk1 Axis in Orbital Fibroblasts From Patients With Thyroid Eye Disease. | Invest Ophthalmol Vis Sci | 2023 | 37272763 | PubTator, text mining | PubMed |
| Discovery and characterization of cyclic peptides selective for the C-terminal bromodomains of BET family proteins. | Structure | 2023 | 37269828 | PubTator, text mining | PubMed |
| Histone modifications in cocaine, methamphetamine and opioids. | Heliyon | 2023 | 37265630 | PubTator, text mining | PubMed |
| PROTACs: A novel strategy for cancer drug discovery and development. | MedComm (2020) | 2023 | 37261210 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6046/papers?page=15